Blog
RSS FeedPosted by Michael Wonder on 31 Oct 2023
New Zealand Pharmaceutical Schedule - 1 November 2023
1 November 2023 - The November 2023 issue of the New Zealand Pharmaceutical Schedule is now available and in effect. ...
Posted by Michael Wonder on 31 Oct 2023
End of temporary funding of palivizumab for preventing RSV
31 October 2023 - Palivizumab has been funded for the last two seasons from funding made available as part of the ...
Posted by Michael Wonder on 27 Oct 2023
PHARMAC boss apologises over stories of patients self-funding treatments
28 October 2023 - PHARMAC's chief executive has apologised for making unprofessional comments about a journalist and stories of cancer ...
Posted by Michael Wonder on 27 Oct 2023
Terminal cancer patient wants 'complete overhaul' of PHARMAC
27 October 2023 - Instead of spending time with her six-year-old daughter, terminal cancer patient Vickie Hudson-Craig is fighting PHARMAC ...
Posted by Michael Wonder on 27 Oct 2023
PHARMAC Board endorse action plan to enhance organisational culture
27 October 2023 - At PHARMAC’s regular monthly Board meeting held today, the Board endorsed the action plan proposed by the ...
Posted by Michael Wonder on 11 Oct 2023
Rare Disorders NZ appalled by attitude within PHARMAC; calls for Chair’s removal
11 October 2023 - Rare Disorders New Zealand is calling on the Minister of Health to remove Steve Maharey as ...
Posted by Michael Wonder on 11 Oct 2023
PHARMAC needs to work for patients, not itself
10 October 2023 - “The internal chaos and siege mentality at PHARMAC is exactly why the next Government needs to ...
Posted by Michael Wonder on 10 Oct 2023
Calls to sack PHARMAC boss after 'sick, sneering' remarks
8 October 2023 - A top cancer specialist says PHARMAC chief executive Sarah Fitt should step down over “offensive” emails, ...
Posted by Michael Wonder on 09 Oct 2023
‘Fund PHARMAC properly’: health advocate’s countrywide journey to discuss medicine funding
10 October 2023 - Patient Voice Aotearoa’s My Life Matters Roadshow came to an end, culminating in a political debate ...
Posted by Michael Wonder on 30 Sep 2023
New Zealand Pharmaceutical Schedule - 1 October 2023
1 October 2023 - The October 2023 issue of the New Zealand Pharmaceutical Schedule is now available and in effect. ...
Posted by Michael Wonder on 20 Sep 2023
Access to COVID-19 anti-viral treatments widened for more people at risk
20 September 2023 - PHARMAC is widening access to COVID-19 anti-virals to people who are vulnerable to severe infection from ...
Posted by Michael Wonder on 18 Sep 2023
COVID-19 vaccine contract summary
18 September 2023 - The Ministry of Health has released a summary of the New Zealand Government’s procurement process for ...
Posted by Michael Wonder on 13 Sep 2023
Treatment options for people with glioma, a type of brain cancer
13 September 2023 - BMS, the supplier of lomustine, a treatment used for a type of brain cancer called glioma, is ...
Posted by Michael Wonder on 11 Sep 2023
Act’s productivity perspective on PHARMAC medication and treatments will hurt minorities
11 September 2023 - Act is proposing a “productivity perspective based on real lives” when it comes to delivering PHARMAC ...
Posted by Michael Wonder on 05 Sep 2023
Oncologists pen open letter to PHARMAC asking for more life-saving cancer drugs
5 September 2023 - Drug buying agency PHARMAC is not moving fast enough, says a gut cancer patient paying more ...